Evidence map›Paper›PMID 34074315›Full record

ArticleOrphanet journal of rare diseases2021

Correction to: Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study.

Eugen Mengel, Bruno Bembi, Mireia Del Toro, Federica Deodato, Matthias Gautschi, Stephanie Grunewald, Sabine Grønborg, Bénédicte Héron, Esther M Maier, Agathe Roubertie and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Eugen MengelSphinCS GmbH, Institute of Clinical Science for LSD, Hochheim, Germany. eugen.mengel@sphincs.de.ORCID http://orcid.org/0000-0001-8967-2951
Bruno BembiRegional Coordinator Centre for Rare Diseases, Academic Hospital Santa Maria Della Misericordia, Udine, Italy.
Mireia Del ToroVall D'Hebron University Hospital, Barcelona, Spain.
Federica DeodatoOspedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
Matthias GautschiInselspital, University Hospital of Bern, Bern, Switzerland.
Stephanie GrunewaldMetabolic Department, Great Ormond Street Hospital NHS Foundation Trust, Institute for Child Health, NIHR Biomedical Research Centre UCL, London, UK.
Sabine GrønborgCentre for Inherited Metabolic Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
Bénédicte HéronReference Centre for Lysosomal Disease, Trousseau University Hospital, Paris, France.
Esther M MaierDr. Von Hauner Children's Hospital, University of Munich, Munich, Germany.
Agathe RoubertieInstitute of Neurosciences, University Hospital of Montpellier, Montpellier, France.
Saikat SantraBirmingham Children's Hospital, Birmingham, UK.
Anna Tylki-SzymanskaChildren's Memorial Health Institute, Warsaw, Poland.
Simon DayClinical Trials Consulting and Training Limited, Buckingham, UK.
Tara SymondsClinical Outcomes Solutions Limited, Folkestone, UK.
Stacie HudgensClinical Outcomes Solutions Inc, Tucson, AZ, USA.
Marc C PattersonMayo Clinic Children's Center, Rochester, MN, USA.
Christina GuldbergOrphazyme A/S, Copenhagen, Denmark.
Linda IngemannOrphazyme A/S, Copenhagen, Denmark.
Nikolaj H T PetersenOrphazyme A/S, Copenhagen, Denmark.
Thomas KirkegaardOrphazyme A/S, Copenhagen, Denmark.
Christine Í DaliOrphazyme A/S, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34074315
PMCPMC8168003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.